Keywords: مهار کننده بازجذب سروتونین انتخابی; AMPA; α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid; AUD; alcohol use disorder; FDA; Food and Drug Administration; GABAAR; γ-aminobutyric acid receptor; NAc; nucleus accumbens; nAChRs; nicotinic acetylcholine receptors; NMDA; N-methyl-d-aspartate
مقالات ISI مهار کننده بازجذب سروتونین انتخابی (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: مهار کننده بازجذب سروتونین انتخابی; pregnancy; selective serotonin reuptake inhibitor; serotonin syndrome; SSRI;
Keywords: مهار کننده بازجذب سروتونین انتخابی; ADHD; Attention deficit hyperactivity disorder; CFC; Chlorofluorocarbon; FDA; Food and Drug Administration; HFA; Hydrofluoroalkane; ICS; Inhaled corticosteroid; SSRI; Selective serotonin reuptake inhibitor;
Keywords: مهار کننده بازجذب سروتونین انتخابی; aBMD; Areal bone mineral density; BMC; Bone mineral content; BMI; Body mass index; DXA; Dual-energy X-ray absorptiometry; LS; Lumbar spine; MPH; Methylphenidate; pQCT; Peripheral quantitative computed tomography; SSRI; Selective serotonin reuptake inhibit
Keywords: مهار کننده بازجذب سروتونین انتخابی; BMD; bone mineral density; CKD; chronic kidney disease; COPD; chronic obstructive pulmonary disease; CRH; corticotropin-releasing hormone; HR; hazard ratio; ICD-9-CM; International Classification of Diseases, Ninth Revision, Clinical Modification; IRR; in
Keywords: مهار کننده بازجذب سروتونین انتخابی; selective serotonin reuptake inhibitor; SSRI; selective norepinephrine reuptake inhibitor; SNRI; depression; risk; pregnancy;
Keywords: مهار کننده بازجذب سروتونین انتخابی; MMN; mismatch negativity; ERP; event-related potential; SZ; schizophrenia; MAO; monoamine oxidase; nAChR; nicotinic acetylcholine receptor; GABA; γ-aminobutyric acid; NMDAR; N-methyl-d-aspartate receptor; PCP; phencyclidine; 5-HT; serotonin; D1; dopamine
Keywords: مهار کننده بازجذب سروتونین انتخابی; Conditioned reinforcement; Selective serotonin reuptake inhibitor; Relapse; Reinstatement; Alcoholism; Alcohol
Keywords: مهار کننده بازجذب سروتونین انتخابی; CMS; chronic mild stress; 2-DE; two-dimensional gel electrophoresis; AK1; adenylate kinase isoenzyme 1; NDKB; nucleoside diphosphate kinase B; HINT1; histidine triad nucleotide-binding protein 1; APT-2; acyl-protein thioesterase 2; GST; glutathione S-tran
Keywords: مهار کننده بازجذب سروتونین انتخابی; cardiac defect; craniosynostosis; major congenital malformations; pregnancy; selective serotonin reuptake inhibitor; sertraline;
Keywords: مهار کننده بازجذب سروتونین انتخابی; Hemorrhage; Antidepressant; 5HT; Stomach; CI; confidence interval; NNH; number needed to harm; NOS; Newcastle-Ottawa Scale; NSAID; nonsteroidal anti-inflammatory drug; OR; odds ratio; SSRI; selective serotonin reuptake inhibitor; UGIB; upper gastrointes
Keywords: مهار کننده بازجذب سروتونین انتخابی; AASM; American Academy of Sleep Medicine; CSF; cerebrospinal fluid; EDS; excessive daytime sleepiness; ESS; Epworth Sleepiness Scale; FDA; US Food and Drug Administration; GABA; gamma-aminobutyric acid; HLA; human leukocyte antigen; ICSD-3; International
Keywords: مهار کننده بازجذب سروتونین انتخابی; ACEi; angiotensin-converting enzyme inhibitor; ADR; adverse drug reaction; CCB; calcium channel blocker; CKD; chronic kidney disease; CNI; calcineurin inhibitor; eGFR; estimated glomerular filtration rate; GFR; glomerular filtration rate; NSAID; nonsteroi
Keywords: مهار کننده بازجذب سروتونین انتخابی; AC; acid ceramidase; ACTH; adrenocorticotropic hormone; AMPA; alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid; ASM; acid sphingomyelinase; BDNF; brain-derived nerve growth factor; CB1; cannabinoid 1 receptor; CDP-DAG; cytidine diphosphate diacylg
Keywords: مهار کننده بازجذب سروتونین انتخابی; 5-HT; 5-hydroxytryptamine, serotonin; CRF; corticotropin-releasing factor; HPA; hypothalamus-pituitary-adrenal; WHO; World Health Organization; DSM-5; Diagnostic and Statistical Manual of Mental Disorders 5; MOA; monoamine oxidase; VMAT; vesicular monoami
Keywords: مهار کننده بازجذب سروتونین انتخابی; Multiple sclerosis; Restless legs syndrome; Polysomnography; Periodic leg movements; International Restless Legs Syndrome Study Group questionnaire; AASM; American Academy of Sleep Medicine; AHI; apnea-hypopnea index; CI; confidence interval; EDSS; Expa
Keywords: مهار کننده بازجذب سروتونین انتخابی; 4HNE; 4-hydroxy-2-nonena 1; AA-NAT; arylalkylamine N-acetylatransferase; AFMK; N1-acetyl-N2-formyl-5-methoxykynuramine; AHr; aryl hydrocarbon receptor; AMK; N1-acetyl-5-methoxykynuramine; Apo; apolipoprotein; cAMP; cyclic adenosine monophosphate; B2-adr;
Keywords: مهار کننده بازجذب سروتونین انتخابی; Fear extinction; Exposure therapy; Augmented relearning; Reconsolidation; Drug development; Cognitive enhancer; 5-HT; 5-hydroxytryptamine = serotonin; AC; adenylate cyclase; AMPA; α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid; AMY; amygdala; BA;
Keywords: مهار کننده بازجذب سروتونین انتخابی; Cutaneous silent period; Escitalopram; Selective serotonin reuptake inhibitor; Placebo; Brainstem descending system;
Keywords: مهار کننده بازجذب سروتونین انتخابی; Selective serotonin reuptake inhibitor; falls; depression; randomized controlled trial; aged;
Keywords: مهار کننده بازجذب سروتونین انتخابی; Selective serotonin reuptake inhibitor; Epilepsy; Antidepressant; Depression; Epileptogenesis; Animal model; Kindling;
Keywords: مهار کننده بازجذب سروتونین انتخابی; NSAID; non-steroidal anti-inflammatory drug; CENTRAL; Cochrane Central Register of Controlled Trials; HRSD; Hamilton Rating Scale for Depression; MDD; Major Depressive Disorder; WHO; World Health Organization; IL-6; interleukin-6; IL-1β; interleukin-1bet
Keywords: مهار کننده بازجذب سروتونین انتخابی; ICD-9; International Classification of Diseases, Ninth Revision; MIMIC; Multiparameter Intelligent Monitoring in Intensive Care; RCT; randomized controlled trial; SAPS; Simplified Acute Physiology Score; SNRI; serotonin norepinephrine reuptake inhibitor;
Keywords: مهار کننده بازجذب سروتونین انتخابی; Beta cell; Antidepressant; Selective serotonin reuptake inhibitor; Mitochondrial dysfunction; Reactive oxygen species; Folic acid;
Keywords: مهار کننده بازجذب سروتونین انتخابی; FLX; fluoxetine hydrochloride; 5-HT; 5-hydroxytryptamine/serotonin; SSRI; selective serotonin reuptake inhibitor; ED; experimental day; 5-Hydroxytryptamine (5-HT); Fluoxetine hydrochloride (Prozacâ¢); Naked mole-rat; Social behavior; Social status;
Keywords: مهار کننده بازجذب سروتونین انتخابی; ADP; adult dentate gyrus-derived neural precursor cells; bFGF; basic fibroblast growth factor; BrdU; 5-bromo-2-deoxyuridine; CNTF; ciliary neurotrophic factor; FBS; fetal bovine serum; GAPDH; glyceraldehyde 3-phosphate dehydrogenase; GCL; granule cell lay
Keywords: مهار کننده بازجذب سروتونین انتخابی; OCT2; organic cation transporter 2; hOCT2; human organic cation transporter 2; MDCK; Madin-Darby canine kidney; TCA; tricyclic antidepressant; SSRI; selective serotonin reuptake inhibitor; SNRI; serotonin-norepinephrine reuptake inhibitor; MAOI; monoa
Keywords: مهار کننده بازجذب سروتونین انتخابی; MDD; major depressive disorder; PIC; proinflammatory cytokine; AIC; anti-inflammatory cytokine; HC; hippocampus; LTP; long term potentiation; HPA; hypothalamus-pituitary-adrenal; 3-HK; 3-hydroxykynurenine; QA; quinolinic acid; IDO; indoleamine-2,3-dioxyge
Keywords: مهار کننده بازجذب سروتونین انتخابی; 5-HIAA; 5-hydroxyindoleacetic acid; 5-HT-5; hydroxytryptamine; ACC; anterior cingulate cortex; AMYG; amygdala; BDNF; brain derived neurotrophic factor; dlPFC; dorsolateral prefrontal cortex; dmPFC; dorsomedial prefrontal cortex; DNA; deoxyribonucleic acid
Keywords: مهار کننده بازجذب سروتونین انتخابی; adolescent; child; meta-analysis; selective serotonin reuptake inhibitor; tricyclic antidepressant; young adult;
Keywords: مهار کننده بازجذب سروتونین انتخابی; ACTH; adrenocorticotropic hormone; ATP; adenosine triphosphate; BD; bipolar depression; BDNF; brain derived neurotrophic factor; BP; bipolar disorder; CMUS; chronic mild unpredictable stress; CUS; chronic unpredictable stress; CRH; corticotropin releasing
Keywords: مهار کننده بازجذب سروتونین انتخابی; 5-HT; serotonin; ACTH; adrenocorticotropic hormone; BDNF; brain-derived neurotrophic factor; BLA; basolateral amygdala; CpG; cytosine phosphate guanosine; CREB; cAMP response element-binding protein; GR; glucocorticoid receptor; HAT; histone acetyltransfe
Keywords: مهار کننده بازجذب سروتونین انتخابی; ACC; anterior cingulate cortex; AMPA; alpha-amino-3-hydroxyl-5-methyl-4-isoxazolepropionic acid; BDNF; brain-derived neurotrophic factor; CaMKII; Ca2+/calmodulin-dependent protein kinase II; cAMP; cyclic adenosine monophosphate; CREB; cAMP-response elemen
Keywords: مهار کننده بازجذب سروتونین انتخابی; Prostaglandin; Stomach; Side Effects; Treatment; AP; proportion attributable to interaction; ATC; Anatomical Therapeutic Chemical; CI; confidence interval; COX-2 inhibitor; cyclooxygenase-2 selective inhibitor; EHR; electronic health record; GPA; gastropr
Keywords: مهار کننده بازجذب سروتونین انتخابی; AGA; American Gastroenterological Association; CI; confidence interval; CSBM; complete spontaneous bowel movement; FDA; Food and Drug Administration; GRADE; Grading of Recommendations Assessment, Development and Evaluation; IBS; irritable bowel syndrome;
Keywords: مهار کننده بازجذب سروتونین انتخابی; Ach; acetylcholine; AchE; acetylcholine esterease; ACTH; adrenocorticotrophic hormone; ADHD; attention deficit/hyperactivity disorder; AIDS; autoimmune deficiency syndrome; AMSH; alpha-melanocyte-stimulating hormone; BAM; bovine adrenal medulla peptide; B
Keywords: مهار کننده بازجذب سروتونین انتخابی; SERT; serotonin transporter; NET; norepinephrine transporter; DAT; dopamine transporter; NSS; neurotransmitter/sodium (Na+/Clâ) symporter; SSRI; selective serotonin reuptake inhibitor; NBD; nitrobenzoxadiazolealanine; NMM; N-methylmorpholine; NHS; N-hyd
Keywords: مهار کننده بازجذب سروتونین انتخابی; SSRI; Selective serotonin reuptake inhibitor; SRI; serotonin reuptake inhibitor; BSID III; Bayley Scale of Infant Development Third edition; EPDS; Edinburgh Postnatal Depression Scale; HAMD; Hamilton Rating Scale for Depression; PA; Positive Affect; Serot
Keywords: مهار کننده بازجذب سروتونین انتخابی; GAD; Generalized anxiety disorder; CON; Control group; GAD-p group; GAD-pharmacotherapy; GAD group; Generalized anxiety disorder group; CBT; cognitive behavioral therapy; SSRI; selective serotonin reuptake inhibitor; SCID-P; Structured Clinical Interview
Keywords: مهار کننده بازجذب سروتونین انتخابی; MDD; major depressive disorder; BMD; bone mineral density; SSRI; selective serotonin reuptake inhibitor; BMI; body mass index; OPG; osteoprotegerin; IPAQ; International Physical Activity Questionnaire; CRP; C-reactive protein; IL-6; interleukin-6; RANKL;
Keywords: مهار کننده بازجذب سروتونین انتخابی; TRD; treatment-resistant depression; TSD; treatment-sensitive depression; FC; functional connectivity; PFC; prefrontal cortex; MFG; middle frontal gyrus; SMA; supplementary motor area; ITG; inferior temporal gyrus; IPL; inferior parietal lobule; MDD; majo
Keywords: مهار کننده بازجذب سروتونین انتخابی; PMDD; premenstrual dysphoric disorder; PWD; progesterone withdrawal; FST; forced swim test; 5-HT; serotonin; SSRI; selective serotonin reuptake inhibitor; SNRI; serotonin norepinephrine reuptake inhibitor; SERT; serotonin transporter; AMI; amitriptyline;
Keywords: مهار کننده بازجذب سروتونین انتخابی; AgRP; agouti-related protein; ANOVA; analysis of variance; b-FGF; basic fibroblast growth factor; BMI; body mass index; BTC; betacellulin; CI; Confidence interval; CRF; corticotropin-releasing factor; CRP; C reactive protein; CTE; childhood trauma exposur
Keywords: مهار کننده بازجذب سروتونین انتخابی; HPA; hypothalamic-pituitary-adrenal; LPS; lipopolysaccharide; COR; corticosterone; SSRI; selective serotonin reuptake inhibitor; FLX; fluoxetine; PND; postnatal day; OF; open field; IZT; inner zone time; IZE; inner zone entries; EPM; elevated plus-maze; O
Keywords: مهار کننده بازجذب سروتونین انتخابی; CNS; central nervous system; DAT; dopamine transporter; GABA; gamma-aminobutyric acid; GAT; gamma-aminobutyric acid (GABA) transporter; GLT; glutamate transporter; iDAT; invertebrate dopamine transporter; NAT; noradrenaline transporter; NTT; neurotransmit
Keywords: مهار کننده بازجذب سروتونین انتخابی; LPS; lipopolysaccharide; HPA; hypothalamic-pituitary-adrenal; PND; postnatal day; FLX; fluoxetine; SSRI; selective serotonin reuptake inhibitor; COR; corticosterone; FST; forced swimming test; TST; tail suspension test; ANOVA; analysis of variance; NP
Keywords: مهار کننده بازجذب سروتونین انتخابی; APIs; active pharmaceutical ingredients; FDA; U.S. Food and Drug Administration; ADRs; adverse drug reactions; DDD; defined daily dose; PBT; persistent, bioaccumulative, toxic; SSRI; selective serotonin reuptake inhibitor; Active pharmaceutical ingredient
Keywords: مهار کننده بازجذب سروتونین انتخابی; ACh; acetylcholine; ADHD; attention deficit hyperactivity disorder; ANOVA; analysis of variance; BSA; bovine serum albumin; CNS; central nervous system; DA; dopamine; dr; dose ratio; FDA; United States Food and Drug Administration; nAChR; nicotinic acetyl
Keywords: مهار کننده بازجذب سروتونین انتخابی; mPFC; medial prefrontal cortex; ACC; anterior cingulate cortex; DG; dentate gyrus; NAc; nucleus accumbens; AMPAR; α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor; NMDAR; N-methyl-d-aspartic acid receptor; VDCC; voltage-dependent calcium ch
Keywords: مهار کننده بازجذب سروتونین انتخابی; Aβ; amyloid β; AADC; L-amino acid decarboxylase; ACC; Anterior cingulate cortex; AD; Alzheimer's disease; aMCI; Amnestic mild cognitive impairment; APP; Amyloid precursor protein; AR; Adrenergic receptor; ATMX; atomoxetine; BDNF; Brain-derived neurotrop